Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Cervical Cancer

  Free Subscription


15.08.2022

1 Ann Transl Med
1 Anticancer Drugs
1 Arch Iran Med
1 Biomed Res Int
1 Bioorg Chem
3 BMC Cancer
1 BMC Public Health
1 BMC Womens Health
1 Brachytherapy
1 Cancer Causes Control
1 Cancer Control
2 Cancer Manag Res
1 Cancer Res Treat
1 Clin Cancer Res
1 Comput Math Methods Med
2 Curr Oncol Rep
1 Cytokine
1 Drug Chem Toxicol
1 Eur J Contracept Reprod Health Care
2 Front Oncol
2 Front Public Health
1 Health Policy
2 Indian J Cancer
2 Infect Agent Cancer
4 Int J Cancer
2 Int J Environ Res Public Health
1 Int J Genomics
3 Int J Mol Sci
1 J Ethnopharmacol
2 J Immunol Res
1 J Natl Compr Canc Netw
1 J Obstet Gynaecol Res
1 Oncol Lett
1 Pathologie (Heidelb)
1 Perm J
2 PLoS One
2 Prev Med Rep
1 Psychol Health Med
1 Rev Bras Ginecol Obstet
1 Sci Rep
2 Strahlenther Onkol
1 Syst Rev
2 Technol Cancer Res Treat
1 Value Health
1 World Neurosurg


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Transl Med

  1. TEIXEIRA JC, Vale DB
    A promising technique to improve and expand the practice of colposcopy to help the global fight against cervical cancer.
    Ann Transl Med. 2022;10:723.
    PubMed        


    Anticancer Drugs

  2. JIANG Y, Xu W, Tao J
    Circular RNA circVPRBP serves as a microRNA-106b-5p sponge to regulate proliferation and metastasis of cervical cancer cells via tripartite motif-containing protein 3.
    Anticancer Drugs. 2022 Aug 10. pii: 00001813-990000000-00037.
    PubMed         Abstract available


    Arch Iran Med

  3. FAKHROLMOBASHERI M, Mousavi Seresht L
    Cost-Effectiveness of HPV vaccination; Need for Economic and Social Policy Intervention.
    Arch Iran Med. 2022;25:343-346.
    PubMed        


    Biomed Res Int

  4. FANG F, Guo C, Zheng W, Li Q, et al
    LINC00707 Promotes Cell Proliferation in Cervical Cancer via the miR-374c-5p/SDC4 Axis.
    Biomed Res Int. 2022;2022:5793912.
    PubMed         Abstract available


    Bioorg Chem

  5. LIU X, Yang R, Xu Q, Zhou M, et al
    Tautomeric phytosterols from Vernonia amygdalina Delile and their anti-cervical cancer activity.
    Bioorg Chem. 2022;128:106068.
    PubMed         Abstract available


    BMC Cancer

  6. NASCIMENTO NPG, Gally TB, Borges GF, Campos LCG, et al
    Systematic review of circulating MICRORNAS as biomarkers of cervical carcinogenesis.
    BMC Cancer. 2022;22:862.
    PubMed         Abstract available

  7. TIITI TA, Selabe SG, Bogers J, Lebelo RL, et al
    High prevalence of and factors associated with human papillomavirus infection among women attending a tertiary hospital in Gauteng Province, South Africa.
    BMC Cancer. 2022;22:854.
    PubMed         Abstract available

  8. LI M, Xiao Y, Liu M, Ning Q, et al
    MiR-26a-5p regulates proliferation, apoptosis, migration and invasion via inhibiting hydroxysteroid dehydrogenase like-2 in cervical cancer cell.
    BMC Cancer. 2022;22:876.
    PubMed         Abstract available


    BMC Public Health

  9. ASANGBEH-KERMAN SL, Davidovic M, Taghavi K, Kachingwe J, et al
    Cervical cancer prevention in countries with the highest HIV prevalence: a review of policies.
    BMC Public Health. 2022;22:1530.
    PubMed         Abstract available


    BMC Womens Health

  10. KIM J, Dove MS, Dang JHT
    Sociodemographic factors associated with HPV awareness/knowledge and cervical cancer screening behaviors among caregivers in the U.S.
    BMC Womens Health. 2022;22:335.
    PubMed         Abstract available


    Brachytherapy

  11. ABDALVAND N, Sadeghi M, Mahdavi SR, Abdollahi H, et al
    Brachytherapy outcome modeling in cervical cancer patients: A predictive machine learning study on patient-specific clinical, physical and dosimetric parameters.
    Brachytherapy. 2022 Aug 3. pii: S1538-4721(22)00113.
    PubMed         Abstract available


    Cancer Causes Control

  12. MILLER EA, Pinsky PF
    Cervical cancer screening and predictors of screening by diabetes status.
    Cancer Causes Control. 2022 Aug 10. pii: 10.1007/s10552-022-01615.
    PubMed         Abstract available


    Cancer Control

  13. EPHREM DIBISA K, Tamiru Dinka M, Mekonen Moti L, Fetensa G, et al
    Precancerous Lesion of the Cervix and Associated Factors Among Women of West Wollega, West Ethiopia, 2022.
    Cancer Control. 2022;29:10732748221117900.
    PubMed         Abstract available


    Cancer Manag Res

  14. TEKA B, Gizaw M, Firdawoke E, Addissie A, et al
    A Technical Comparison of Human Papillomavirus Genotyping Assays from a Population-Based Cervical Cancer Screening in South Central Ethiopia.
    Cancer Manag Res. 2022;14:2253-2263.
    PubMed         Abstract available


  15. Long Intergenic Non-Coding RNA LINC00885 Promotes Tumorigenesis of Cervical Cancer by Upregulating MACC1 Expression Through Serving as a Competitive Endogenous RNA for microRNA-432-5p [Expression of Concern].
    Cancer Manag Res. 2022;14:2307-2308.
    PubMed        


    Cancer Res Treat

  16. LEE TH, Kim KS, Kim HJ, Choi CH, et al
    Image-Guided Versus Conventional Brachytherapy for Locally Advanced Cervical Cancer: Experience of Single Institution with the Same Practitioner and Time Period.
    Cancer Res Treat. 2022 Aug 10. pii: crt.2022.418. doi: 10.4143/crt.2022.
    PubMed         Abstract available


    Clin Cancer Res

  17. MILLER KM, Friedman CF
    Bifunctional Blockade: A Novel Immunotherapy Approach for Cervical Cancer.
    Clin Cancer Res. 2022 Aug 10. pii: 707611. doi: 10.1158/1078-0432.CCR-22-1779.
    PubMed         Abstract available


    Comput Math Methods Med

  18. WU Y, Chen T, Huang Y, Li Y, et al
    MRI Using Artificial Intelligence Algorithm to Evaluate Concurrent Chemoradiotherapy for Local Recurrence and Distant Metastasis of Cervical Squamous Cell Carcinoma.
    Comput Math Methods Med. 2022;2022:4449696.
    PubMed         Abstract available


    Curr Oncol Rep

  19. BATMAN SH, Schmeler KM
    Fertility-Sparing and Less Radical Surgery for Cervical Cancer.
    Curr Oncol Rep. 2022 Aug 12. pii: 10.1007/s11912-022-01317.
    PubMed         Abstract available

  20. MARCHOCKI Z, Swift B, Covens A
    Small Cell and Other Rare Histologic Types of Cervical Cancer.
    Curr Oncol Rep. 2022 Aug 10. pii: 10.1007/s11912-022-01316.
    PubMed         Abstract available


    Cytokine

  21. MONROY-MORA A, de Lourdes Mora-Garcia M, Alheli Monroy Mora K, Hernandez-Montes J, et al
    Inhibition of adenosine deaminase activity reverses resistance to the cytotoxic effect of high adenosine levels in cervical cancer cells.
    Cytokine. 2022;158:155977.
    PubMed         Abstract available


    Drug Chem Toxicol

  22. IBARRA-BERUMEN J, Moreno-Eutimio MA, Rosales-Castro M, Ordaz-Pichardo C, et al
    Cytotoxic effect and induction of apoptosis in human cervical cancer cells by a wood extract from Prosopis laevigata.
    Drug Chem Toxicol. 2022 Aug 11:1-13. doi: 10.1080/01480545.2022.2109046.
    PubMed         Abstract available


    Eur J Contracept Reprod Health Care

  23. BAHAMONDES L, Maria Y Makuch
    Awareness of the non-contraceptive benefits of reversible contraceptive methods in a cohort of Brazilian women: an exploratory study.
    Eur J Contracept Reprod Health Care. 2022;27:294-299.
    PubMed         Abstract available


    Front Oncol

  24. CHEN F, Chen L, Zhang Y, Shi L, et al
    Survival Comparison Between Squamous Cell Carcinoma and Adenocarcinoma for Radiotherapy-Treated Patients with Stage IIB-IVA Cervical Cancer.
    Front Oncol. 2022;12:895122.
    PubMed         Abstract available

  25. MENG S, Liu Y, Wang X, Wu X, et al
    The prognostic value and biological significance of gap junction beta protein 2 (GJB2 or Cx26) in cervical cancer.
    Front Oncol. 2022;12:907960.
    PubMed         Abstract available


    Front Public Health

  26. LU H, Li L, Cheng Y, Yang Z, et al
    Timely Estimates of 5-Year Relative Survival for Patients With Cervical Cancer: A Period Analysis Using Cancer Registry Data From Taizhou, Eastern China.
    Front Public Health. 2022;10:926058.
    PubMed         Abstract available

  27. CHUA BWB, Neo P, Ma VY, Lim LM, et al
    Health care provider's experience and perspective of cervical cancer screening in Singapore: A qualitative study.
    Front Public Health. 2022;10:853453.
    PubMed         Abstract available


    Health Policy

  28. CHAN DNS, Law BMH, So WKW, Fan N, et al
    Factors associated with cervical cancer screening utilisation by people with physical disabilities: A systematic review.
    Health Policy. 2022 Aug 3. pii: S0168-8510(22)00219.
    PubMed         Abstract available


    Indian J Cancer

  29. AKCAY M, Etiz D, Celik O, Ozen A, et al
    Evaluation of acute hematological toxicity by machine learning in gynecologic cancers using postoperative radiotherapy.
    Indian J Cancer. 2022;59:178-186.
    PubMed         Abstract available

  30. SHIM SJ, Kim NY, Lee HJ, Gong SJ, et al
    Successful treatment of a patient with recurrent metastatic clear cell carcinoma of the uterine cervix.
    Indian J Cancer. 2022;59:269-272.
    PubMed         Abstract available


    Infect Agent Cancer

  31. GIZAW AT, El-Khatib Z, Wolancho W, Amdissa D, et al
    Uptake of cervical cancer screening and its predictors among women of reproductive age in Gomma district, South West Ethiopia: a community-based cross-sectional study.
    Infect Agent Cancer. 2022;17:43.
    PubMed         Abstract available

  32. WARDEN CD, Cholli P, Qin H, Guo C, et al
    HPV genotyping by L1 amplicon sequencing of archived invasive cervical cancer samples: a pilot study.
    Infect Agent Cancer. 2022;17:44.
    PubMed         Abstract available


    Int J Cancer

  33. GIORGI ROSSI P, Ronco G, Mancuso P, Carozzi F, et al
    Performance of HPV E6/E7 mRNA Assay as Primary Screening Test. Results from the NTCC2 Trial.
    Int J Cancer. 2022 May 17. doi: 10.1002/ijc.34120.
    PubMed         Abstract available

  34. SAUVAGET C, Bazikamwe S, Lucas E, Ndayikengurukiye A, et al
    Evaluation of effectiveness, acceptability and safety of thermal ablation in the treatment of cervical neoplasia in Burundi.
    Int J Cancer. 2022;151:1120-1126.
    PubMed         Abstract available

  35. ADCOCK R, Nedjai B, Lorincz A, Scibior-Bentkowska D, et al
    DNA methylation testing with S5 for triage of high-risk HPV positive women.
    Int J Cancer. 2022 Apr 27. doi: 10.1002/ijc.34050.
    PubMed         Abstract available

  36. DESAI KT, Adepiti CA, Schiffman M, Egemen D, et al
    Redesign of a rapid, low-cost HPV typing assay to support risk-based cervical screening and management.
    Int J Cancer. 2022 Jun 6. doi: 10.1002/ijc.34151.
    PubMed         Abstract available


    Int J Environ Res Public Health

  37. ANDIWIJAYA FR, Davey C, Bessame K, Ndong A, et al
    Disability and Participation in Breast and Cervical Cancer Screening: A Systematic Review and Meta-Analysis.
    Int J Environ Res Public Health. 2022;19.
    PubMed         Abstract available

  38. ZIBAKO P, Hlongwa M, Tsikai N, Manyame S, et al
    Mapping Evidence on Management of Cervical Cancer in Sub-Saharan Africa: Scoping Review.
    Int J Environ Res Public Health. 2022;19.
    PubMed         Abstract available


    Int J Genomics

  39. QIN L, Luo X, Qin X, Huang H, et al
    Comprehensive Expression Profiling and Molecular Basis of CDC28 Protein Kinase Regulatory Subunit 2 in Cervical Cancer.
    Int J Genomics. 2022;2022:6084549.
    PubMed         Abstract available


    Int J Mol Sci

  40. MORAND GB, Cardona I, Cruz SBSC, Mlynarek AM, et al
    Therapeutic Vaccines for HPV-Associated Oropharyngeal and Cervical Cancer: The Next De-Intensification Strategy?
    Int J Mol Sci. 2022;23.
    PubMed         Abstract available

  41. TRYBUS W, Trybus E, Krol T
    Emodin Sensitizes Cervical Cancer Cells to Vinblastine by Inducing Apoptosis and Mitotic Death.
    Int J Mol Sci. 2022;23.
    PubMed         Abstract available

  42. MUNOZ-BELLO JO, Carrillo-Garcia A, Lizano M
    Epidemiology and Molecular Biology of HPV Variants in Cervical Cancer: The State of the Art in Mexico.
    Int J Mol Sci. 2022;23.
    PubMed         Abstract available


    J Ethnopharmacol

  43. VIDAL-GUTIERREZ M, Torres-Moreno H, Arenas-Luna V, Loredo-Mendoza ML, et al
    Standardized phytopreparations and cucurbitacin IIb from Ibervillea sonorae (S. Watson) greene induce apoptosis in cervical cancer cells by Nrf2 inhibition.
    J Ethnopharmacol. 2022 Aug 6:115606. doi: 10.1016/j.jep.2022.115606.
    PubMed         Abstract available


    J Immunol Res

  44. LANG X, Huang C, Cui H
    Prognosis Analysis and Validation of Fatty Acid Metabolism-Related lncRNAs and Tumor Immune Microenvironment in Cervical Cancer.
    J Immunol Res. 2022;2022:4954457.
    PubMed         Abstract available

  45. QIN W, He C, Jiang D, Gao Y, et al
    Systematic Construction and Validation of a Novel Ferroptosis-Related Gene Model for Predicting Prognosis in Cervical Cancer.
    J Immunol Res. 2022;2022:2148215.
    PubMed         Abstract available


    J Natl Compr Canc Netw

  46. LI X, Rao X, Wei MJ, Lu WG, et al
    Extended HPV Genotyping for Risk Assessment of Cervical Intraepithelial Neoplasia Grade 2/3 or Worse in a Cohort Study.
    J Natl Compr Canc Netw. 2022;20:906-914.
    PubMed         Abstract available


    J Obstet Gynaecol Res

  47. TERADA S, Terai Y, Tanaka Y, Tanaka T, et al
    Postsurgical urodynamic study of total laparoscopic nerve-sparing radical hysterectomy for uterine cervical cancer.
    J Obstet Gynaecol Res. 2022 Aug 7. doi: 10.1111/jog.15371.
    PubMed         Abstract available


    Oncol Lett

  48. XU Z, Huang L, Zhang T, Liu Y, et al
    Shikonin inhibits the proliferation of cervical cancer cells via FAK/AKT/GSK3beta signalling.
    Oncol Lett. 2022;24:304.
    PubMed         Abstract available


    Pathologie (Heidelb)

  49. HORN LC, Beckmann MW, Follmann M, Koch MC, et al
    [Revised German guidelines on the diagnosis and treatment of carcinoma of the uterine cervix-what's new for pathologists in 2021?]
    Pathologie (Heidelb). 2022;43:292-302.
    PubMed         Abstract available


    Perm J

  50. JAQUA E, Nguyen V, Morton K, Chin E, et al
    Improving Cervical Cancer Screening Rates at an Urban Federally Qualified Health Center Family Medicine Residency Clinic.
    Perm J. 2022;26:21-27.
    PubMed         Abstract available


    PLoS One

  51. YANG Z, Zhang Y, Stubbe-Espejel A, Zhao Y, et al
    Vaginal microbiota and personal risk factors associated with HPV status conversion-A new approach to reduce the risk of cervical cancer?
    PLoS One. 2022;17:e0270521.
    PubMed         Abstract available

  52. JO A, Joh HM, Bae JH, Kim SJ, et al
    Plasma activated medium prepared by a bipolar microsecond-pulsed atmospheric pressure plasma jet array induces mitochondria-mediated apoptosis in human cervical cancer cells.
    PLoS One. 2022;17:e0272805.
    PubMed         Abstract available


    Prev Med Rep

  53. CATARINO R, Vassilakos P, Petignat P, Combescure C, et al
    Harms and benefits of cervical cancer screening among non-attenders in Switzerland: The transition towards HPV-based screening.
    Prev Med Rep. 2022;29:101929.
    PubMed         Abstract available

  54. HO FDV, Arevalo MVPN, de Claro PTS, Jacomina LE, et al
    Breast and cervical cancer screening in the Philippines: Challenges and steps forward.
    Prev Med Rep. 2022;29:101936.
    PubMed         Abstract available


    Psychol Health Med

  55. QIAN M, Wang L, Xing J, Shan X, et al
    Prevalence of sexual dysfunction in women with cervical cancer: a systematic review and meta-analysis.
    Psychol Health Med. 2022 Aug 10:1-15. doi: 10.1080/13548506.2022.2110270.
    PubMed         Abstract available


    Rev Bras Ginecol Obstet

  56. BRUM VOR, Tricoti ASO, Pannain GD, Drumond DG, et al
    Cytology-based Screening for Anal Intraepithelial Neoplasia in Immunocompetent Brazilian Women with a History of High-Grade Cervical Intraepithelial Neoplasia or Cancer.
    Rev Bras Ginecol Obstet. 2022;44:678-685.
    PubMed         Abstract available


    Sci Rep

  57. WANG J, Chen Y, Xie H, Luo L, et al
    Evaluation of auto-segmentation for EBRT planning structures using deep learning-based workflow on cervical cancer.
    Sci Rep. 2022;12:13650.
    PubMed         Abstract available


    Strahlenther Onkol

  58. BEN DHIA S, Berthou H, Warcoin M, Rodrigues M, et al
    Combined-modality treatment for locally advanced cervical cancer in a woman with Bloom-like syndrome: A case report and review of the literature.
    Strahlenther Onkol. 2022 Aug 5. pii: 10.1007/s00066-022-01981.
    PubMed         Abstract available

  59. HERMESSE J, Pleyers C, Gennigens C, De Cuypere M, et al
    Outcome analysis of HDR compared to PDR IGABT in locally advanced cervical cancer: a single-center cohort analysis.
    Strahlenther Onkol. 2022 Aug 9. pii: 10.1007/s00066-022-01982.
    PubMed         Abstract available


    Syst Rev

  60. SEFUTHI T, Nkonki L
    A systematic review of economic evaluations of cervical cancer screening methods.
    Syst Rev. 2022;11:162.
    PubMed         Abstract available


    Technol Cancer Res Treat

  61. CHEN Y, Chen J, Lin X, Zheng J, et al
    A Prognostic Nomogram for Predicting Overall Survival in Patients With Small-Cell Carcinoma of the Uterine Cervix: A SEER Population-Based Study.
    Technol Cancer Res Treat. 2022;21:15330338221110673.
    PubMed         Abstract available

  62. MEIXNER E, Hoeltgen L, Hoegen P, Konig L, et al
    Age-Dependent Hematologic Toxicity Profiles and Prognostic Serologic Markers in Postoperative Radiochemotherapy Treatment for Uterine Cervical Cancer.
    Technol Cancer Res Treat. 2022;21:15330338221118188.
    PubMed         Abstract available


    Value Health

  63. MA S, Olchanski N, Cohen JT, Ollendorf DA, et al
    The Impact of Broader Value Elements on Cost-Effectiveness Analysis: Two Case Studies.
    Value Health. 2022;25:1336-1343.
    PubMed         Abstract available


    World Neurosurg

  64. KIM J, Heo DH, Lee DC, Park CK, et al
    Surgical Removal of Cervical Extradural Cysts Using the Biportal Endoscopic Approach.
    World Neurosurg. 2022;164:228-236.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: